Modular Medical, Inc. (MODD)
| Market Cap | 22.17M -39.8% |
| Revenue (ttm) | n/a |
| Net Income | -28.03M |
| EPS | -8.77 |
| Shares Out | 8.15M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 43,354 |
| Open | 2.670 |
| Previous Close | 2.660 |
| Day's Range | 2.620 - 2.772 |
| 52-Week Range | 1.720 - 20.289 |
| Beta | 0.30 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About MODD
Modular Medical, Inc. operates as a medical device company. The company focuses on the design, development, and commercialization of insulin pumps. It offers Pivot product, a tubeless insulin delivery system that integrates the set into a true tubeless patch. Modular Medical, Inc. is headquartered in San Diego, California.
Financial Performance
Financial StatementsNews
Modular Medical to Present at the Webull Emerging & Innovative Companies Webinar on October 14th
SAN DIEGO, CA / ACCESS Newswire / October 7, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercia...
Modular Medical Proxy statement: Proxy filing
Modular Medical filed a proxy statement on October 1, 2026, providing details for shareholder voting and corporate governance matters.
Modular Medical Slides: Investor presentation
Modular Medical has posted slides in relation to its latest quarterly earnings report, which was published on September 15, 2026.
Modular Medical to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 on September 15-16, 2026
SAN DIEGO, CA / ACCESS Newswire / September 8, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commerc...
Modular Medical secures contract with national U.S. pharmacy benefit manager
Modular Medical (MODD) has secured a contract with a national U.S. pharmacy benefit manager in the United States. Pursuant to the contract, the Company’s Pivot insulin delivery system is now…
Modular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump
SAN DIEGO, CA / ACCESS Newswire / September 4, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the commercial l...
Modular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements
Clearance Covers Software Enhancements for Greater Patient Flexibility and Pivot Customization SAN DIEGO, CA / ACCESS Newswire / September 3, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Co...
Registration is Now Open for Tribe Public's CEO Presentation and Q&A Webinar Event Titled ''The Road To Revenue: Modular Medical's Strategy For Launching Pivot'' Featuring Modular Medical CEO - Friday, September 4, 2026
Meet with Modular Medical CEO Jeb Besser. Discover The Pivot tubeless patch pump, a simple, wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion with both ba...
Modular Medical Quarterly report: Q1 2027
Modular Medical has published its Q1 2027 quarterly earnings report on August 14, 2026.
Modular Medical registers to sell 193K shares of common stock for holders
This filing relates to the offer and sale from time to time by the selling stockholders of up to 193K shares of common stock. The company is not selling any…
Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference
SAN DIEGO, CA / ACCESS Newswire / August 5, 2026 / Modular Medical, Inc ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial ...
Modular Medical Registration statement: Registration filing
Modular Medical filed a registration statement on August 5, 2026, providing details about a securities offering with the SEC.
Modular Medical announces launch of Pivot insulin delivery system
Modular Medical (MODD) announced plans to initiate the first phase of commercialization of its Pivot tubeless patch pump across five strategically selected U.S. markets beginning in October 2026. The ...
Modular Medical Announces Launch of Pivot Insulin Delivery System Across Five Key U.S. Markets Beginning October 2026
First Phase of Strategic Rollout Targets Markets with Leading Insulin Pump Prescribers and Strong New Pump Adoption. Inizio will Provide Commercialization Expertise to Accelerate Awareness and Adoptio...
Modular Medical announces formation of Pivot Innovation Council
Modular Medical (MODD) announced the formation of its Pivot Innovation Council. Diabetes care expert Robert Gabbay, MD, PhD, FACP was appointed as chair of the Pivot Innovation Council. The council…
Modular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman
- Council to Provide Strategic Clinical Guidance on Commercialization, Patient Identification, Workflow Integration, and Evidence Generation SAN DIEGO, CA / ACCESS Newswire / July 23, 2026 / Modular M...
Modular Medical, IMO Health launch strategic pilot
Modular Medical (MODD) announced an important pilot collaboration with IMO Health. Through this pilot, Modular Medical and IMO Health expect to develop a deployable terminology-powered phenotypic algo...
Modular Medical and IMO Health Launch Strategic Pilot to Enable Real Time Insulin Pump Patient Identification Into Electronic Health Records
Pilot Combines Clinician Guided Phenotypes with IMO Health's Unique Terminology Identifiers to Help Clinicians Easily Identify Patients Most Likely to Benefit from Pivot Insulin Pump Therapy Advancing...
Modular Medical releases findings from independent study on Pivot pump
Modular Medical (MODD) released findings from an independent market research study demonstrating positive receptivity to its FDA-cleared Pivot tubeless patch pump due to its differentiated design, str...
Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump
Completed Independent Study Strongly Supports Favorable Payor Receptivity to Pivot's Differentiated Design and Simplified User Experience, and provides further validation of significant progress towar...
Modular Medical reports findings from diabetes patient research initiative
Modular Medical (MODD) announced findings from a new comprehensive diabetes patient research initiative further supporting its commercialization strategy. The Company will share these findings and sho...
Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery
97% of Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved Outcomes Conducting Additional Research Initiative in Conjunction with Commercialization of the Pivot Tube...
Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements
Submission Covers Software Enhancements for Patient Flexibility and Customization of Pivot SAN DIEGO, CA / ACCESS Newswire / July 1, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (...
Modular Medical delivers insulin to first patients on Pivot pump
Modular Medical (MODD) announced that the first patients have completed onboarding and training and are now actively using the Pivot tubeless insulin patch pump in real-world settings. This milestone ...
Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump
First Patients Began Device Training and Insulin Delivery Today, Marking Transition to a Commercial Company Pivot is the First Insulin Pump Designed to Address the Large, Underserved Population of Ins...